Buccal misoprostol for treatment of fetal death at 14-28 weeks of pregnancy: A double-blind randomized controlled trial

Contraception

Volumn 89, Issue 3, 2014, Pages 187-192

  Bracken, Hillary ^a   Ngoc, Nguyen Thi Nhu ^b   Banks, Erika ^c   Blumenthal, Paul D ^d   Derman, Richard J ^e   Patel, Ashlesha ^f   Gold, Marji ^c   Winikoff, Beverly ^a  

^a GYNUITY HEALTH PROJECTS   (United States)

^b Center for Research and Consultancy in Reproductive Health   (Viet Nam)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d STANFORD UNIVERSITY   (United States)

^e CHRISTIANA CARE HEALTH SYSTEM   (United States)

^f Jr Hospital of Cook County   (United States)

Author keywords

Buccal misoprostol; Intrauterine fetal demise

Indexed keywords

MISOPROSTOL; NARCOTIC ANALGESIC AGENT; OXYTOCIN;

ADOLESCENT; ADULT; ANALGESIA; ANTIBIOTIC THERAPY; ARTICLE; CHILL; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG INDUCED HEADACHE; FEMALE; FETUS; FETUS DEATH; FORCEPS DELIVERY; GESTATIONAL AGE; HEALTH CARE QUALITY; HOSPITALIZATION; HUMAN; LABOR INDUCTION; LIKERT SCALE; MAJOR CLINICAL STUDY; MATERNAL AGE; PAIN; PARITY; PELVIC INFLAMMATORY DISEASE; PLACENTA; PLACENTAL DELIVERY; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW (TOPIC); TABLET; TREATMENT DURATION; VAGINA BLEEDING; VAGINAL DELIVERY; VOMITING; YOUNG ADULT;

BUCCAL MISOPROSTOL; INTRAUTERINE FETAL DEMISE;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ADMINISTRATION, BUCCAL; ADULT; DELIVERY, OBSTETRIC; DOUBLE-BLIND METHOD; FEMALE; FETAL DEATH; GESTATIONAL AGE; HUMANS; LABOR, INDUCED; MISOPROSTOL; OXYTOCIN; PREGNANCY; TREATMENT OUTCOME; UNITED STATES; VIETNAM;

EID: 84896546074     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2013.11.014     Document Type: Article

References (17)

1. S. Cousens, H. Blencowe, C. Stanton, D. Chou, S. Ahmed, and L. Steinhardt et al. National, regional, and worldwide estimates of stillbirth rates in 2009 with trends since 1995: a systematic analysis Lancet 377 9774 2011 1319 1330
2. L.P. Shulman, G.H. Lipscomb, and F.W. Ling Management of abnormal pregnancies M. Paul, E.S. Lichtenberg, L. Borgatta, D.A. Grimes, P.G. Stubblefield, A Clinician's Guide to Medical and Surgical Abortion 1999 W.B. Saunders Company Castro Valley, CA
3. R. Romero, J.A. Copel, and J.C. Hobbins Intrauterine fetal demise and hemostatic failure: the fetal death syndrome Clin Obstet Gynecol 28 1 1985 24 31 (Pubitemid 15138102)
4. J.M. Dodd, and C.A. Crowther Misoprostol for induction of labour to terminate pregnancy in the second or third trimester for women with a fetal anomaly or after intrauterine fetal death Cochrane Database Syst Rev 4 2010 CD004901
5. W. Vayrynen, O. Heikinheimo, and M. Nuutila Misoprostol-only versus mifepristone plus misoprostol in induction of labor following intrauterine fetal death Acta Obstet Gynecol 86 2007 701 705 (Pubitemid 46801786)
6. D. Sharma, S.R. Singhal, Poonam, A. Paul, and Kunika Comparison of mifepristone combination with misoprostol and misoprostol alone in the management of intrauterine death: condensation - misoprostol and mifepristone combination is more effective than misoprostol alone in the management of intrauterine death. Taiwan J Obstet Gynecol 50 3 2011 Sep 322 325
7. Royal College of Obstetricians and Gynaecologists (RCOG). Late intrauterine fetal death and stillbirth. London (UK): Royal College of Obstetricians and Gynaecologists (RCOG); 2010 Oct. 33 p. (Green-top guideline; no. 55). Accessed on January 7, 2013 at http://www.rcog.org.uk/files/rcog-orp/ GTG%2055%20Late%20Intrauterine%20fetal%20death%20and%20stillbirth%2010%2011%201 0.pdf.
8. S.J. Carlan, D. Blust, and W.F. O'Brien Buccal versus intravaginal misoprostol for cervical ripening Am J Obstet Gynecol 186 2002 229 233 (Pubitemid 34165438)
9. G. Muzonzini, and G.J. Hofmeyr Buccal or sublingual misoprostol for cervical ripening and induction of labor Cochrane Database Syst Rev 4 2004 CD004221
10. B. Winikoff, I.G. Dzuba, M.D. Creinin, W.A. Crowden, A.B. Goldberg, and J. Gonzales et al. Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial Obstet Gynecol 112 2008 1303 1310
11. N.T. Ngoc, T. Shochet, S. Raghavan, J. Blum, N.T. Nga, and N.T. Minh et al. Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial Obstet Gynecol 118 3 2011 Sep 601 608
12. S.C. Ellis, N. Kapp, O. Vragpvoc, and L. Borgata Randomized trial of buccal versus vaginal misoprostol for induction of second trimester abortion Contraception 81 2010 441 445
13. O.S. Tang, H. Schweer, H.W. Seberth, S. Lee, and P.C. Ho Pharmacokinetics of different routes of administration of misoprostol Hum Reprod 17 2 2002 332 336 (Pubitemid 34168436)
14. K.R. Meckstroth, A.K. Whitaker, S. Bertisch, A. Goldberg, and P. Darney Misoprostol administered by epithelial routes Obstet Gynecol 108 3 2006 582 590
15. W. Clark, C. Shannon, and B. Winikoff Misoprostol for uterine evacuation in induced abortion and pregnancy failure Expert Rev Obstet Gynecol 2 1 2007
16. J.E. Dickinson, M.E. Godfrey, and S.F. Evans Efficacy of intravaginal misoprostol in second-trimester pregnancy termination: a randomized controlled trial J Matern Fetal Med 7 1998 115 119
17. J. Dickinson, and S. Evans The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination Am J Obstet Gynecol 2002 471 474